StockData

Community Healthcare Trust vs National Healthcare Properties

CHCT and NHP side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CHCT and NHP compare

National Healthcare Properties is the larger company, worth 2.9 times as much as Community Healthcare Trust ($1.1B against $374M).

Community Healthcare Trust grew revenue faster over the last twelve months (5.7% versus −1.2% for National Healthcare Properties).

Both pay dividends: Community Healthcare Trust yields 13.5% and National Healthcare Properties 0.99%.

Community Healthcare Trust scores higher on the StockData Score (13 against 4 for National Healthcare Properties), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCHCTNHP
Size and price
Market cap$374M$1.1B
Share price$13.06$15.08
Change, 1 year−9.5%–
Change, 5 years−72.6%–
Beta (5Y)0.68–
Employees3531
StockData Score
Total score13 (better)4
Valuation score5 (better)2
Growth score11
Performance score3 (better)0
Health score00
Dividend score4 (better)1
Valuation
P/E19.5×–
P/S3.0× (better)3.2×
P/B0.9× (better)1.0×
EV/EBITDA–10.4×
Fair value$24.20$15.73
Margin of safety46.0% (better)4.2%
Growth
Revenue growth (TTM)5.7% (better)−1.2%
Revenue growth, 5Y average9.9% (better)−2.2%
EPS growth, 5Y average−36.9%–
Profitability
Gross margin–37.9%
Operating margin–3.2%
Net margin16.8%–
Return on equity4.9%–
Return on invested capital–1.3%
Financial health
Interest coverage–0.2×
Altman Z-score0.510.91 (better)
Piotroski F-score5–
Dividends and buybacks
Dividend yield13.5% (better)0.99%
Payout ratio260%–
Years of dividend growth10–
Dividend growth, 5Y average2.3%–
Shareholder yield13.5% (better)0.99%
Ownership
Held by institutions80.8%72.9%
Held by insiders6.8%0.35%
Insider net buying, 12 months$332K–
Superinvestors holding1–
Short interest, % of float3.2%4.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.